MCRB
Seres Therapeutics Inc
NASDAQ: MCRB · HEALTHCARE · BIOTECHNOLOGY
$7.05
-0.56% today
Updated 2026-04-29
Market cap
$67.91M
P/E ratio
11.02
P/S ratio
86.07x
EPS (TTM)
$0.64
Dividend yield
—
52W range
$7 – $30
Volume
0.1M
Seres Therapeutics Inc (MCRB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.54M | $2.13M | $117.34M | $216.90M | $272.65M | $189.52M | $120.47M | $132.44M | $342.94M | $354.86M | $348.78M | $358.60M | $139.81M |
| Cash & equivalents | $6.21M | $1.65M | $114.19M | $73.93M | $54.54M | $36.09M | $85.82M | $65.13M | $116.05M | $180.00M | $163.03M | $127.97M | $30.79M |
| Current assets | $6.25M | $1.71M | $114.24M | $207.61M | $198.37M | $155.08M | $92.67M | $100.19M | $268.78M | $303.63M | $194.76M | $175.41M | $38.67M |
| Total liabilities | $178000.00 | $1.49M | $144.07M | $11.51M | $140.01M | $128.82M | $168.52M | $180.76M | $168.19M | $223.35M | $338.00M | $403.46M | $126.03M |
| Current liabilities | $178000.00 | $1.06M | $5.10M | $10.92M | $30.46M | $31.63M | $42.04M | $45.99M | $46.41M | $82.26M | $85.60M | $98.66M | $41.22M |
| Long-term debt | — | $438000.00 | $1.30M | $0.00 | $0.00 | $0.00 | — | $24.65M | $24.64M | $24.64M | $50.59M | $101.54M | — |
| Shareholder equity | $6.36M | $631000.00 | $-26.72M | $205.39M | $132.63M | $60.70M | $-48.05M | $-48.32M | $174.75M | $131.51M | $10.78M | $-44.86M | $13.78M |
| Retained earnings | $-4.36M | $-11.12M | $-27.83M | $-82.61M | $-174.19M | $-263.57M | $-389.37M | $-459.65M | $-548.78M | $-614.35M | $-864.51M | $-978.24M | $-978.10M |
| Accounts receivable | — | — | — | — | — | — | — | $1.78M | $9.39M | $0.00 | — | $8.67M | $4.75M |
| Inventory | — | — | — | $0.00 | $0.00 | $0.00 | — | $-29.69M | $1.00 | — | $0.00 | $29.65M | — |
| Goodwill | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |